Skip to content

Randomised Controlled Trial of Cognitive Behavior Therapy and Education for Reduction in Postconcussive Syndrome Symptoms In Mild Traumatic Brain Injury Patients

Randomised Controlled Trial of Cognitive Behavior Therapy and Education for Reduction in Postconcussive Syndrome Symptoms In Mild Traumatic Brain Injury Patients

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12610000969066
Enrollment
60
Registered
2010-11-10
Start date
2011-01-01
Completion date
Unknown
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

This study will investigate whether providing cognitive behaviour therapy provides better reduction of postconcussive syndrome symptoms than education about postconcussive syndrome in patients following mild traumatic brain injury. Patients will be randomly allocate patients with postconcussive syndrome to either (a) cognitive behavior therapy, or (b) education, and assessed for postconcussive symptoms following treatment.

Interventions

Cognitive Behavior Therapy: Therapy is administered in once-weekly 60-minute telephone calls with a clinical psychologist over 5 weeks. Cognitive Behavior Therapy includes education about postconcussive syndrome, imaginal reliving of the trauma memories, in vivo exposure that includes gradual exposure to feared situations, and cognitive restructuring of the trauma experience and the postconcussive syndrome symptoms. The duration of the study for any participant will conclude after the 3-month

Cognitive Behavior Therapy: Therapy is administered in once-weekly 60-minute telephone calls with a clinical psychologist over 5 weeks. Cognitive Behavior Therapy includes education about postconcussive syndrome, imaginal reliving of the trauma memories, in vivo exposure that includes gradual exposure to feared situations, and cognitive restructuring of the trauma experience and the postconcussive syndrome symptoms. The duration of the study for any participant will conclude after the 3-month follow-up assessment, resulting in participation duration of a maximum of 5 months.

Sponsors

University of New South Wales
Lead SponsorUniversity

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Blinded (masking used)

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

(1) Experience a mild traumatic brain injury, (2) Displays postconcusssive syndrome

Exclusion criteria

Suicidal intent, psychotic, substance dependent

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026